---
title: "The innovative drug concept surged and then fell back, with Sinovac Biotech dropping over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244811067.md"
description: "36Kr learned that, as of the time of publication, the innovative drug concept has risen and then fallen, with Sinovac Biotech down over 10%, Baheal Medical and HWPC down over 7%, and companies like Xinlitai, KHPG, InventisBio, and Dizal Pharmaceutical also following the decline"
datetime: "2025-06-17T02:52:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244811067.md)
  - [en](https://longbridge.com/en/news/244811067.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244811067.md)
generator: "portal-rs"
---

# The innovative drug concept surged and then fell back, with Sinovac Biotech dropping over 10%

36Kr learned that as of the time of publication, the innovative drug concept has risen and then fallen, with Sinovac Biotech down over 10%, Baheal Medical and HWPC down over 7%, and companies such as Xinlitai, KHPG, InventisBio, and Dizal Pharmaceutical also experiencing declines

### Related Stocks

- [688799.CN](https://longbridge.com/en/quote/688799.CN.md)
- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)
- [688136.CN](https://longbridge.com/en/quote/688136.CN.md)
- [688382.CN](https://longbridge.com/en/quote/688382.CN.md)
- [688192.CN](https://longbridge.com/en/quote/688192.CN.md)
- [301015.CN](https://longbridge.com/en/quote/301015.CN.md)
- [002294.CN](https://longbridge.com/en/quote/002294.CN.md)

## Related News & Research

- [04:03 ETDizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026](https://longbridge.com/en/news/296585269.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)
- [China NMPA clears InnoCare Phase III trial of mesutoclax-azacitidine in treatment-naive AML](https://longbridge.com/en/news/296164458.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**